Detalles de la búsqueda
1.
Introduction of biosimilar pegfilgrastim in France: Economic analysis of switching from originator.
J Oncol Pharm Pract
; 27(7): 1604-1615, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-33019875
2.
Interaction between healthcare professionals and parents is a key determinant of parental distress during childhood hospitalisation for respiratory syncytial virus infection (European RSV Outcomes Study [EROS]).
Acta Paediatr
; 107(5): 854-860, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29341239
3.
Impact of using the International Risk Scoring Tool on the cost-utility of palivizumab for preventing severe respiratory syncytial virus infection in Canadian moderate-to-late preterm infants.
J Med Econ
; 26(1): 630-643, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37067826
4.
Identifying the research, advocacy, policy and implementation needs for the prevention and management of respiratory syncytial virus lower respiratory tract infection in low- and middle-income countries.
Front Pediatr
; 10: 1033125, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36440349
5.
Challenges in the prevention or treatment of RSV with emerging new agents in children from low- and middle-income countries.
Expert Rev Anti Infect Ther
; 19(4): 419-441, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32972198
6.
Adoption in Canada of an international risk scoring tool to predict respiratory syncytial virus hospitalization in moderate-to-late preterm infants.
Curr Med Res Opin
; 37(7): 1149-1153, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33813989
7.
IBD2020 global forum: results of an international patient survey on quality of care.
Intest Res
; 16(4): 537-545, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-30301341
8.
Risk scoring tool to predict respiratory syncytial virus hospitalisation in premature infants.
Pediatr Pulmonol
; 53(5): 605-612, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29405612
9.
The influence of birth weight amongst 33-35 weeks gestational age (wGA) infants on the risk of respiratory syncytial virus (RSV) hospitalisation: a pooled analysis.
J Matern Fetal Neonatal Med
; 30(2): 134-140, 2017 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26965584
10.
Can we improve the targeting of respiratory syncytial virus (RSV) prophylaxis in infants born 32-35 weeks' gestational age with more informed use of risk factors?
J Matern Fetal Neonatal Med
; 28(10): 1133-41, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25048748
Resultados
1 -
10
de 10
1
Próxima >
>>